Comparative Pharmacology
Head-to-head clinical analysis: CORTIFOAM versus DEXASPORIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CORTIFOAM versus DEXASPORIN.
CORTIFOAM vs DEXASPORIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cortifoam (hydrocortisone acetate) is a corticosteroid that binds to glucocorticoid receptors, modulating gene expression to induce anti-inflammatory, antipruritic, and vasoconstrictive effects. It inhibits phospholipase A2, reducing prostaglandin and leukotriene synthesis, and suppresses immune cell migration and cytokine release.
Dexasporin is a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It binds to the glucocorticoid receptor, leading to modulation of gene expression and inhibition of pro-inflammatory mediators such as prostaglandins and leukotrienes.
1 applicatorful (90 mg hydrocortisone acetate) rectally twice daily for 2-3 weeks, then every other day as needed.
1 to 2 mg/kg intramuscular or intravenous every 8 hours.
None Documented
None Documented
Approximately 1.5-2 hours for hydrocortisone; clinically, effects persist longer due to local action.
3-4 hours (prolonged to 10-15 hours in renal impairment; monitor CrCl <30 mL/min)
Primarily renal (about 70-90% as metabolites) and fecal (about 10-30% as metabolites).
Renal excretion (80-90% unchanged), biliary/fecal (10-20%)
Category C
Category C
Corticosteroid
Corticosteroid/Antibiotic Combination